Analytical method development and method validation for assay, related substances and degradants of acyclovir and valacyclovir as antiviral drug products

dc.contributor.guideRokade, Manoj Den_US
dc.coverage.spatialChemistryen_US
dc.creator.researcherHolkar, Ganesh Shahanebuwaen_US
dc.date.accessioned2013-12-11T05:26:05Z
dc.date.available2013-12-11T05:26:05Z
dc.date.awarded16-09-2013en_US
dc.date.completed31-12-2012en_US
dc.date.issued2013-12-11
dc.date.registered9-10-2010en_US
dc.description.abstractFrom the Literature study it is unable to find the combined HPLC methods for Acyclovir and Valacyclovir using HPLC-UV detector. However, an analytical method for individual analysis for Acyclovir and Valacyclovir was published. So It is felt necessary that to develop HPLC method for quantitative determination of Acyclovir and Valacyclovir. It was also found that there are some analytical methods reported for the Acyclovir and valacyclovir separately and most of the works reported were done on the biological fluids. Based upon the data of previous literature review and results of published methods, the trials of method development taken and finalized the method for validation of assay and related substances with degradants study. The finalized method is achieved on HPLC column Inertsil cyno column, (250and#61620;4.6mm dimensions) having particle size 5and#61549;m, with flow rate as 0.8 ml/ min and column oven temperature as 50o C. The buffer was prepared by dissolving 1.00 g of Ammonium acetate in 1000 ml water, filtered through 0.45µm membrane filter and degassed in ultrasonic bath prior to use as mobile phase A . Acetonitrile is the organic solvent used as mobile phase B in isocratic mode. The injection volume amounted to 5and#61549;l. The analysis was carried out under isocratic condition as mobile phase A: Mobile phase B is (95:5). Detection was monitored at the wavelength of 254 nm. Diluent used was a mixture of acetonitrile and water in the ratio of (50:50) in the preparation of analytical solutions. According to the International Conference on Harmonization (ICH) guidelines taking into consideration the specified limits for Acyclovir and Valacyclovir Tablets and based upon the results obtained from the method validation are summarized below,en_US
dc.description.noteSummary p. 142-160, References p. 161-165en_US
dc.format.accompanyingmaterialNoneen_US
dc.format.dimensions--en_US
dc.format.extent165p.en_US
dc.identifier.urihttp://hdl.handle.net/10603/13919
dc.languageEnglishen_US
dc.publisher.institutionFaculty of Sciencesen_US
dc.publisher.placeJhunjhunuen_US
dc.publisher.universityShri Jagdishprasad Jhabarmal Tibarewala Universityen_US
dc.relation--en_US
dc.rightsuniversityen_US
dc.source.universityUniversityen_US
dc.subject.keywordChemistryen_US
dc.titleAnalytical method development and method validation for assay, related substances and degradants of acyclovir and valacyclovir as antiviral drug productsen_US
dc.type.degreePh.D.en_US

Files

Original bundle

Now showing 1 - 5 of 15
Loading...
Thumbnail Image
Name:
01_title.pdf
Size:
7.17 KB
Format:
Adobe Portable Document Format
Description:
Attached File
Loading...
Thumbnail Image
Name:
02_declaration.pdf
Size:
5.6 KB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
03_certificate.pdf
Size:
5.39 KB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
04_acknowledgements.pdf
Size:
6.41 KB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
05_index.pdf
Size:
52.97 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: